Aardvark Therapeutics Statistics
NASDAQ: AARDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.9226-0.0774 (-7.74%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Aardvark Therapeutics by the numbers
Aardvark Therapeutics has a market capitalization of $20.2 million based on 21.89M shares outstanding. With trailing EPS of $-3.33, Aardvark Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 72.4% below its 50-day average and 82.8% below its 200-day average.
Average daily trading volume is 643.53K shares, or about $593,724 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AARD valuation vs. peer median
| Metric | AARD | Peer median | Difference |
|---|---|---|---|
| Market cap | $20.20M | $19.70M | +3% |
| Avg. volume | 643.53K | 380.08K | +69% |
Peer median across 8 companies: RNAZ, ACET, TXMD, IGC, CPHI, CRVO, COCP, MRKR.
Valuation
- Market cap
- $20.20M
- EPS (TTM)
- $-3.33
- Shares outstanding
- 21.89M
Price and trading
- Previous close
- 1.00
- Open
- 1.00
- Day range
- 0.90 – 1.06
- 52-week range
- 0.90 – 16.60
- 52-week change
- -90.15%
- Beta
- —
- Volume
- 241.07K
- Average volume
- 643.53K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 13, 2026
Additional statistics
- Market Cap
- 20.20M
- Forward Pe
- -0.39
- Eps
- -3.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 16.60
- Week52 Low
- 0.90
- Avg Volume
- 643.53K
- Shares Outstanding
- 21.89M
- Ma50
- 3.35
- Ma200
- 5.36
- Earnings Date
- Nov 13, 2026
- Pct From52w High
- -94.44%
- Pct From52w Low
- 2.51%